Arzeda
Arzeda harnesses the power of Intelligent Protein Design Technology™, combining physics-based protein design and AI algorithms to create, validate, and manufacture new designer proteins and enzymes that enhance our lives and protect our planet. In collaboration with Fortune 500 companies and industrial leaders, Arzeda develops and commercializes healthier and more sustainable products across the food and nutrition, consumer products, advanced materials, agriculture, diagnostics, and pharmaceutical industries globally, fulfilling the promise of biotechnology.
Sector
Industrial Biotech
Strategy
Status
Live
Website
www.arzeda.com
SofinnovaCapital
The Sofinnova Capital Strategy acts as a founding and lead investor in early-stage biopharma and medtech start-ups focusing on groundbreaking therapeutic technologies.
SofinnovaMD Start
The MD Start Strategy is Sofinnova’s in-house medtech accelerator. The team’s hands-on entrepreneurial expertise contributes to the platform's global leadership in company building.
SofinnovaCrossover
The Sofinnova Crossover Strategy supports ground-breaking innovations in later-stage biotech and medtech companies, enabling ambitious life sciences companies to reach their full potential.
SofinnovaIndustrial Biotech
Our Industrial Biotech Strategy seeks early-stage investments that will have a positive impact on sustainability in the chemicals, agriculture, food and materials sectors.
SofinnovaTelethon
The Sofinnova Telethon Strategy seeks early-stage projects to bring the best Italian science to the world stage.
SofinnovaDigital Medicine
The Sofinnova Digital Medicine Strategy backs early-stage startups at the intersection of biology, data and computation.
SofinnovaBiovelocita
The Sofinnova Biovelocita Strategy is dedicated entirely to the creation and acceleration of European biotech startups, in partnership with leading research organizations.